drugset / Trial / NCT00986713

Value of Amphotericin B Inhalation for Prophylaxis of Invasive Pulmonary Aspergillosis After Renal Transplantation

NCT00986713

Phase 4 Unknown 400 enrolled Capital Medical University
RandomizedParallel-groupSingle-blindPrevention

Summary

The purpose of this study is to determine whether inhalation with aerosolized amphoterin B 10mg/d is more effective than aerosolized amphoterin B 2mg/d to reduce the incidence of invasive pulmonary aspergillosis.

Timeline

Start
2008-06
Primary completion
2010-09
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Amphotericin B Unknown 2 mg Inhaled
Subject Amphotericin B Unknown 10 mg Inhaled